Hims & Hers Navigates Novo Nordisk Breakup And Compounding Lawsuits

Hims & Hers Navigates Novo Nordisk Breakup And Compounding Lawsuits

Upworthy

Published

Hims & Hers Health, Inc. (NYSE:HIMS) is currently experiencing a decline in its stock price, trading lower on Monday. The company’s stock has plummeted approximately 18% over the past month, reflecting recent challenges. A significant development contributing to this decline occurred in June 2025,…

Full Article